LT2315773T - Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui - Google Patents

Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui

Info

Publication number
LT2315773T
LT2315773T LTEP09781052.7T LT09781052T LT2315773T LT 2315773 T LT2315773 T LT 2315773T LT 09781052 T LT09781052 T LT 09781052T LT 2315773 T LT2315773 T LT 2315773T
Authority
LT
Lithuania
Prior art keywords
tubeculosis
polynucleotides
polypeptides
latent
compositions
Prior art date
Application number
LTEP09781052.7T
Other languages
English (en)
Inventor
James Brown
Pascal Mettens
Dennis Murphy
Original Assignee
Glaxosmithkline Biologicals S.A.
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A., Glaxo Group Limited filed Critical Glaxosmithkline Biologicals S.A.
Publication of LT2315773T publication Critical patent/LT2315773T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
LTEP09781052.7T 2008-07-25 2009-07-24 Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui LT2315773T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8372008P 2008-07-25 2008-07-25
PCT/EP2009/059580 WO2010010177A1 (en) 2008-07-25 2009-07-24 Novel compositions and methods

Publications (1)

Publication Number Publication Date
LT2315773T true LT2315773T (lt) 2016-11-10

Family

ID=41217660

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP09781052.7T LT2315773T (lt) 2008-07-25 2009-07-24 Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui

Country Status (24)

Country Link
US (2) US20110117119A1 (lt)
EP (1) EP2315773B1 (lt)
JP (1) JP5873332B2 (lt)
KR (1) KR20110044883A (lt)
CN (1) CN102164952B (lt)
AU (1) AU2009273130B2 (lt)
BR (1) BRPI0916703A2 (lt)
CA (1) CA2731499C (lt)
CO (1) CO6341637A2 (lt)
CY (1) CY1118200T1 (lt)
DK (1) DK2315773T3 (lt)
EA (1) EA024826B1 (lt)
ES (1) ES2602430T3 (lt)
HR (1) HRP20161458T1 (lt)
HU (1) HUE031044T2 (lt)
IL (1) IL210559A0 (lt)
LT (1) LT2315773T (lt)
MX (1) MX2011000983A (lt)
PL (1) PL2315773T3 (lt)
PT (1) PT2315773T (lt)
SG (1) SG192456A1 (lt)
SI (1) SI2315773T1 (lt)
UA (1) UA107330C2 (lt)
WO (1) WO2010010177A1 (lt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144447B1 (en) * 1998-11-04 2009-10-14 Isis Innovation Limited Tuberculosis diagnostic test
EP2315834B1 (en) 2008-07-25 2018-06-13 GlaxoSmithKline Biologicals S.A. The tuberculosis rv2386c protein, compositions and uses thereof
EA022203B1 (ru) 2008-07-25 2015-11-30 Глаксосмитклайн Байолоджикалс С.А. Способы и композиции для лечения или предупреждения туберкулёза
EP2156945A1 (en) 2008-08-13 2010-02-24 Novelis Inc. Clad automotive sheet product
WO2010121618A1 (en) 2009-04-24 2010-10-28 Statens Serum Institut A tuberculosis tb vaccine to prevent reactivation
JP6010463B2 (ja) 2010-01-27 2016-10-19 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 改変された結核抗原
NZ717647A (en) * 2013-09-27 2020-06-26 Codexis Inc Structure based predictive modeling
AU2014324669B2 (en) 2013-09-27 2020-06-04 Codexis, Inc. Automated screening of enzyme variants
GB201405921D0 (en) * 2014-04-02 2014-05-14 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
CN106546737A (zh) * 2016-10-24 2017-03-29 广州迪澳医疗科技有限公司 一种体外检测活动性结核的方法
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
BR112019025193A2 (pt) 2017-05-30 2020-06-23 Glaxosmithkline Biologicals S.A. Métodos de fabricação de um adjuvante lipossomal, de fabricação de um concentrado lipossomal, para a preparação de uma composição imunogênica com adjuvante e para a preparação de uma solução, adjuvante lipossomal, composição imunogênica com adjuvante, e, solução
CN111670044A (zh) 2017-12-01 2020-09-15 葛兰素史密丝克莱恩生物有限公司 皂苷纯化
CN114080393A (zh) 2019-06-05 2022-02-22 葛兰素史克生物有限公司 皂苷纯化

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087713B2 (en) * 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
BR9909472A (pt) * 1998-04-07 2001-09-11 Corixa Corp Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
DK2133100T3 (da) * 2000-06-20 2012-01-23 Corixa Corp MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf
JP3840596B2 (ja) * 2001-01-08 2006-11-01 アイシス・イノベーション・リミテッド ミコバクテリア感染のための治療の効力を決定するためのアッセイ法
US7538206B2 (en) * 2001-02-22 2009-05-26 Institut Pasteur Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
US20030236393A1 (en) * 2002-03-22 2003-12-25 United States Of America Dept Of Vetrans Affairs Virulence genes of M. marinum and M. tuberculosis
US7678379B2 (en) * 2004-06-17 2010-03-16 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
CN101273055B (zh) 2005-04-29 2016-03-16 葛兰素史密丝克莱恩生物有限公司 用于预防或治疗结核分枝杆菌感染的新方法
JP5219808B2 (ja) * 2005-06-23 2013-06-26 ステイテンス・セラム・インスティテュート 改良された結核ワクチン
WO2008007942A1 (en) * 2006-07-10 2008-01-17 Het Nederlands Kanker Instituut Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof
EP2368568A1 (en) * 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions and methods for immunodominant antigens
WO2010121618A1 (en) * 2009-04-24 2010-10-28 Statens Serum Institut A tuberculosis tb vaccine to prevent reactivation
JP6010463B2 (ja) 2010-01-27 2016-10-19 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 改変された結核抗原

Also Published As

Publication number Publication date
JP2011528895A (ja) 2011-12-01
HRP20161458T1 (hr) 2016-12-16
CO6341637A2 (es) 2011-11-21
MX2011000983A (es) 2011-03-02
WO2010010177A1 (en) 2010-01-28
CN102164952B (zh) 2016-05-25
HUE031044T2 (en) 2017-06-28
SI2315773T1 (sl) 2016-12-30
US20140178423A1 (en) 2014-06-26
JP5873332B2 (ja) 2016-03-01
US20110117119A1 (en) 2011-05-19
KR20110044883A (ko) 2011-05-02
AU2009273130A1 (en) 2010-01-28
CN102164952A (zh) 2011-08-24
CA2731499C (en) 2017-01-10
UA107330C2 (uk) 2014-12-25
PT2315773T (pt) 2016-11-23
EP2315773B1 (en) 2016-08-24
DK2315773T3 (en) 2016-12-12
EP2315773A1 (en) 2011-05-04
EA024826B1 (ru) 2016-10-31
SG192456A1 (en) 2013-08-30
EA201100072A1 (ru) 2011-10-31
CY1118200T1 (el) 2017-06-28
IL210559A0 (en) 2011-03-31
AU2009273130B2 (en) 2014-10-16
US9795663B2 (en) 2017-10-24
CA2731499A1 (en) 2010-01-28
ES2602430T3 (es) 2017-02-21
PL2315773T3 (pl) 2017-07-31
BRPI0916703A2 (pt) 2019-12-24

Similar Documents

Publication Publication Date Title
LT2315773T (lt) Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui
AP2965A (en) Therapeutic compositions and the use thereof
AP2490A (en) Therapeutic compositions and the use thereof
PL1975226T3 (pl) Płynna kompozycja do obróbki
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
IL207096A0 (en) Modified leptin polypeptides and their uses
IL195152A (en) Compounds for use in treating diseases of cell culture
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
IL215592A (en) Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
PL2190405T3 (pl) Kompozycje do traktowania włosów
EP2172524A4 (en) RESIN COMPOSITION AND USE THEREOF
EP2209458A4 (en) SKIN TREATMENT COMPOSITIONS
PL2066408T3 (pl) Kompozycja na bazie ksantoksyliny i jej zastosowanie w kosmetyce
GB0719202D0 (en) Compositions and methods for the skin and hair
MX303262B (es) Composicion de locion para uso personal.
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
GB0822486D0 (en) Compounds for use in the treatment of pain
GB0714500D0 (en) composition and treatment
GB2461611B (en) Composition and use thereof
ZA200807156B (en) Liquid treatment composition
ZA201000469B (en) Therapeutic compositions and the use thereof
GB0622040D0 (en) Skin treatment composition
HK1172547A1 (en) Activin-actrii antagonists for use in treating anemia -actrii
GB0810409D0 (en) Composition and use thereof